E
Trinity Biotech plc
TRIB
$0.6792
-$0.0588-7.97%
E
Sell
12/19/2023Downgrade
Trinity Biotech plc (TRIB) was downgraded to E+ from D- on 12/19/2023 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.03 to 1.28.
Trinity Biotech plc (TRIB) was downgraded to E+ from D- on 12/19/2023 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.03 to 1.28.
D
Sell
5/24/2023Upgraded
Trinity Biotech plc (TRIB) was upgraded to D- from E+ on 5/24/2023 due to an increase in the volatility index.
Trinity Biotech plc (TRIB) was upgraded to D- from E+ on 5/24/2023 due to an increase in the volatility index.
E
Sell
5/8/2023Downgrade
Trinity Biotech plc (TRIB) was downgraded to E+ from D- on 5/8/2023 due to a decline in the volatility index.
Trinity Biotech plc (TRIB) was downgraded to E+ from D- on 5/8/2023 due to a decline in the volatility index.
D
Sell
4/21/2023Upgraded
Trinity Biotech plc (TRIB) was upgraded to D- from E+ on 4/21/2023 due to an increase in the volatility index.
Trinity Biotech plc (TRIB) was upgraded to D- from E+ on 4/21/2023 due to an increase in the volatility index.
E
Sell
4/6/2023Downgrade
Trinity Biotech plc (TRIB) was downgraded to E+ from D- on 4/6/2023 due to a noticeable decline in the volatility index and total return index.
Trinity Biotech plc (TRIB) was downgraded to E+ from D- on 4/6/2023 due to a noticeable decline in the volatility index and total return index.
D
Sell
3/14/2023Downgrade
Trinity Biotech plc (TRIB) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
Trinity Biotech plc (TRIB) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
Trinity Biotech plc (TRIB) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and total return index.
Trinity Biotech plc (TRIB) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and total return index.
D
Sell
2/8/2023Downgrade
Trinity Biotech plc (TRIB) was downgraded to D- from D on 2/8/2023 due to a large decline in the growth index and total return index. Earnings per share declined from -$0.242 to -$1.144, EBIT declined 194.82% from $965 to -$915, and operating cash flow declined 150.09% from $3.86M to -$1.93M.
Trinity Biotech plc (TRIB) was downgraded to D- from D on 2/8/2023 due to a large decline in the growth index and total return index. Earnings per share declined from -$0.242 to -$1.144, EBIT declined 194.82% from $965 to -$915, and operating cash flow declined 150.09% from $3.86M to -$1.93M.
D
Sell
11/23/2021Upgraded
Trinity Biotech plc (TRIB) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
Trinity Biotech plc (TRIB) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
Trinity Biotech plc (TRIB) was downgraded to D- from D on 11/8/2021 due to a large decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.2808 to -$1.9184, and debt to equity increased from -116.44 to -39.55.
Trinity Biotech plc (TRIB) was downgraded to D- from D on 11/8/2021 due to a large decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.2808 to -$1.9184, and debt to equity increased from -116.44 to -39.55.
D
Sell
5/29/2020Upgraded
Trinity Biotech plc (TRIB) was upgraded to D from D- on 5/29/2020 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 1,070.31% from $229 to $2.68M, and earnings per share increased from -$4.5848 to -$0.0404.
Trinity Biotech plc (TRIB) was upgraded to D from D- on 5/29/2020 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 1,070.31% from $229 to $2.68M, and earnings per share increased from -$4.5848 to -$0.0404.
D
Sell
10/3/2019Upgraded
Trinity Biotech plc (TRIB) was upgraded to D- from E+ on 10/3/2019 due to an increase in the volatility index.
Trinity Biotech plc (TRIB) was upgraded to D- from E+ on 10/3/2019 due to an increase in the volatility index.
E
Sell
9/10/2019Downgrade
Trinity Biotech plc (TRIB) was downgraded to E+ from D- on 9/10/2019 due to a decline in the solvency index, total return index and growth index. Earnings per share declined from $0.1136 to -$4.5848, operating cash flow declined 86.82% from $1.74M to $229, and debt to equity increased from 1.43 to 1.86.
Trinity Biotech plc (TRIB) was downgraded to E+ from D- on 9/10/2019 due to a decline in the solvency index, total return index and growth index. Earnings per share declined from $0.1136 to -$4.5848, operating cash flow declined 86.82% from $1.74M to $229, and debt to equity increased from 1.43 to 1.86.
D
Sell
7/21/2017Downgrade
Trinity Biotech plc (TRIB) was downgraded to D- from D on 7/21/2017 due to a significant decline in the efficiency index, solvency index and valuation index. Net income declined 4,894.01% from $2.1M to -$100.87M, debt to equity increased from 0.47 to 0.85, and total capital declined 34.83% from $309.9M to $201.96M.
Trinity Biotech plc (TRIB) was downgraded to D- from D on 7/21/2017 due to a significant decline in the efficiency index, solvency index and valuation index. Net income declined 4,894.01% from $2.1M to -$100.87M, debt to equity increased from 0.47 to 0.85, and total capital declined 34.83% from $309.9M to $201.96M.
D
Sell
11/18/2016Downgrade
Trinity Biotech plc (TRIB) was downgraded to D from D+ on 11/18/2016 due to a decline in the total return index and volatility index.
Trinity Biotech plc (TRIB) was downgraded to D from D+ on 11/18/2016 due to a decline in the total return index and volatility index.
D
Sell
7/22/2016Downgrade
Trinity Biotech plc (TRIB) was downgraded to D+ from C- on 7/22/2016 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0935 to -$0.2199, and total capital declined 2.38% from $314.19M to $306.72M.
Trinity Biotech plc (TRIB) was downgraded to D+ from C- on 7/22/2016 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0935 to -$0.2199, and total capital declined 2.38% from $314.19M to $306.72M.
C
Hold
3/11/2016Downgrade
Trinity Biotech plc (TRIB) was downgraded to C- from C+ on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
Trinity Biotech plc (TRIB) was downgraded to C- from C+ on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
C
Hold
2/1/2016Downgrade
Trinity Biotech plc (TRIB) was downgraded to C+ from B- on 2/1/2016 due to a decline in the total return index.
Trinity Biotech plc (TRIB) was downgraded to C+ from B- on 2/1/2016 due to a decline in the total return index.
B
Buy
1/15/2016Downgrade
Trinity Biotech plc (TRIB) was downgraded to B- from B on 1/15/2016 due to a noticeable decline in the total return index.
Trinity Biotech plc (TRIB) was downgraded to B- from B on 1/15/2016 due to a noticeable decline in the total return index.
B
Buy
12/31/2015Upgraded
Trinity Biotech plc (TRIB) was upgraded to B from B- on 12/31/2015 due to a major increase in the growth index, valuation index and total return index.
Trinity Biotech plc (TRIB) was upgraded to B from B- on 12/31/2015 due to a major increase in the growth index, valuation index and total return index.
B
Buy
9/11/2015Upgraded
Trinity Biotech plc (TRIB) was upgraded to B- from C+ on 9/11/2015 due to an increase in the valuation index and dividend index.
Trinity Biotech plc (TRIB) was upgraded to B- from C+ on 9/11/2015 due to an increase in the valuation index and dividend index.
C
Hold
8/24/2015Downgrade
Trinity Biotech plc (TRIB) was downgraded to C+ from B- on 8/24/2015 due to a decline in the volatility index and total return index.
Trinity Biotech plc (TRIB) was downgraded to C+ from B- on 8/24/2015 due to a decline in the volatility index and total return index.
B
Buy
8/7/2015Upgraded
Trinity Biotech plc (TRIB) was upgraded to B- from C+ on 8/7/2015 due to a major increase in the valuation index and growth index. Operating cash flow increased 470.68% from $1.61M to $9.19M, and total revenue increased 0.5% from $26.01M to $26.13M.
Trinity Biotech plc (TRIB) was upgraded to B- from C+ on 8/7/2015 due to a major increase in the valuation index and growth index. Operating cash flow increased 470.68% from $1.61M to $9.19M, and total revenue increased 0.5% from $26.01M to $26.13M.
C
Hold
1/5/2015Upgraded
Trinity Biotech plc (TRIB) was upgraded to C+ from C on 1/5/2015 due to an increase in the volatility index.
Trinity Biotech plc (TRIB) was upgraded to C+ from C on 1/5/2015 due to an increase in the volatility index.
C
Hold
12/19/2014Downgrade
Trinity Biotech plc (TRIB) was downgraded to C from C+ on 12/19/2014 due to a decline in the volatility index, valuation index and dividend index.
Trinity Biotech plc (TRIB) was downgraded to C from C+ on 12/19/2014 due to a decline in the volatility index, valuation index and dividend index.
C
Hold
12/4/2014Upgraded
Trinity Biotech plc (TRIB) was upgraded to C+ from C on 12/4/2014 due to an increase in the total return index, valuation index and dividend index.
Trinity Biotech plc (TRIB) was upgraded to C+ from C on 12/4/2014 due to an increase in the total return index, valuation index and dividend index.
C
Hold
11/19/2014Downgrade
Trinity Biotech plc (TRIB) was downgraded to C from C+ on 11/19/2014 due to a major decline in the volatility index, total return index and efficiency index.
Trinity Biotech plc (TRIB) was downgraded to C from C+ on 11/19/2014 due to a major decline in the volatility index, total return index and efficiency index.
C
Hold
8/18/2014Downgrade
Trinity Biotech plc (TRIB) was downgraded to C+ from B- on 8/18/2014 due to a noticeable decline in the volatility index, growth index and valuation index.
Trinity Biotech plc (TRIB) was downgraded to C+ from B- on 8/18/2014 due to a noticeable decline in the volatility index, growth index and valuation index.
B
Buy
8/1/2014Upgraded
Trinity Biotech plc (TRIB) was upgraded to B- from on 8/1/2014 due to a significant increase in the volatility index, solvency index and efficiency index. Net income increased 21.19% from $3.83M to $4.64M, and total capital increased 4.69% from $174.82M to $183.01M.
Trinity Biotech plc (TRIB) was upgraded to B- from on 8/1/2014 due to a significant increase in the volatility index, solvency index and efficiency index. Net income increased 21.19% from $3.83M to $4.64M, and total capital increased 4.69% from $174.82M to $183.01M.
NASDAQ
03/12/2025 4:00PM Eastern
Quotes delayed
